**
In a heartbreaking incident that underscores Nigeria’s ongoing struggle with snakebite fatalities, the tragic demise of 26-year-old soprano Ifunanya Nwangene has ignited urgent discussions regarding medical preparedness and the availability of antivenom across the nation. After being bitten by a snake in her own home, Nwangene’s desperate search for treatment revealed alarming deficiencies in the healthcare system, particularly in the management of snakebite cases, which claim thousands of lives annually.
A Fatal Encounter
On Saturday morning, Ifunanya was jolted awake by excruciating pain radiating from her wrist. Her father, Christopher Nwangene, recounted the harrowing details of that fateful morning, revealing that a snake had slithered onto her bed and struck. Recognising the gravity of the situation, Ifunanya quickly sought medical intervention, applying a tourniquet—a method once recommended but now deemed dangerous due to the risk of tissue damage.
The urgency of her condition escalated as she was taken to a nearby hospital, only to discover that crucial antivenom was unavailable. This led to a frantic search for alternative treatment options. As her father and uncle rushed to find the necessary medication, Ifunanya’s health deteriorated. “She said, ‘Daddy, I cannot speak,’” Christopher recalled, as her condition worsened despite receiving some antivenom.
Systemic Failures Exposed
The harrowing circumstances surrounding Ifunanya’s death have thrust Nigeria’s public health crisis into the spotlight. The Federal Medical Centre in Jabi has disputed claims that antivenom was unavailable, yet the Nwangene family’s experience reflects a broader issue: a critical shortage of accessible and affordable antivenom in many regions. The World Health Organization categorizes venomous snakebites as a neglected tropical disease, attributing approximately 30,000 deaths per year in sub-Saharan Africa to this preventable cause.
A polyvalent antivenom, which can treat bites from various snake species, is commonly used in Nigeria. However, its high cost, ranging from 45,000 to 80,000 naira (approximately £24 to £43), and the requirement for refrigeration pose significant barriers, particularly in areas with unreliable electricity. The tragic reality is compounded by a lack of effective emergency protocols and training among medical staff to address snakebite emergencies appropriately.
A Nation in Mourning
Ifunanya’s untimely passing has resonated deeply within her community and beyond. Friends and family have expressed their grief, while her death has sparked a vital conversation about snakebites, often dismissed as a rural problem despite their prevalence. The shocking discovery of two snakes in her apartment, one identified as a potentially lethal forest cobra, has only intensified public concern.
In response to this tragedy, the Nigerian Senate has called on the health ministry to ensure better access to antivenom throughout the nation, yet the motion lacks a clear timeline for implementation. Meanwhile, efforts to address the underlying public health crisis remain urgent and necessary.
Seeking Solutions
The stories of survival and loss due to snakebites are all too familiar to many Nigerians. Individuals like Shuaibu Mohammed, who survived a snakebite 15 years ago, contrast sharply with those like Sadiya, a mother who succumbed to a snakebite due to delayed treatment. The reliance on traditional remedies, while common, often leads to unrecorded deaths and a lack of accurate data regarding the scale of the crisis.
Experts are calling for a comprehensive strategy to integrate snakebite management into Nigeria’s healthcare framework. Elhadj As Sy, chancellor of the Liverpool School of Tropical Medicine, emphasized that “with real political commitment, we can end these preventable deaths.” Innovations in antivenom production and distribution are on the horizon, yet immediate action is essential to prevent further tragedies.
Why it Matters
The death of Ifunanya Nwangene serves as a grim reminder of the urgent need for reform in Nigeria’s healthcare system, particularly regarding snakebite management. As the country grapples with this hidden epidemic, the demand for accessible antivenom and proper medical training becomes increasingly critical. Such systemic failures not only endanger lives but also highlight the pressing need for political will and public health initiatives to safeguard communities against this silent killer. In honouring Ifunanya’s memory, Nigeria stands at a crossroads, where action could avert future tragedies and save countless lives.
